PharmaEssentia (TWSE: 6446) today announced its net revenues for July 2025: On a consolidated basis, revenues for July 2025 were approximately NT$1.30 billion, an increase of 8.76% from June 2025 and an increase of 48.01% from July 2024. The year-to-date consolidated revenue totaled NT$8.16 billion, an increase of 68.65%.